98.27%
Lot
HAL-202608-765
Purity
99.03%
- Form
- Lyophilised powder
- Storage
- −20 °C, desiccated
- Stability
- 24 months
- CAS
- 86168-78-7
- Formula
- C149H246N44O42S
- Molecular weight
- 3357.88 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
Sermorelin
GHRH(1-29) amide
£54
Vial massSERMORELIN-2-HAL
1
82 vials in stock · dispatched within 24 h
The shortest fully active fragment of human growth hormone releasing hormone, amidated at the C-terminus. A common reference compound in receptor comparison studies.
GHRH-R assaysComparative analogue work
Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.
Analysis
Certificate of analysis
UPLC-MS chromatogramJanoshik Analytical
Retention time (min)λ 214 nm
Purity99.03%
Specification ≥ 98.0%
- Lot
- HAL-202608-765
- Released
- 2026-08-23
- Mass expected
- 3357.88 Da
- Mass found
- 3357.84 Da
- Water (KF)
- 3.62%
- Endotoxin
- 0.060 EU/mg
- Appearance
- White lyophilisate
Primary structure
29 residues
Hover a residue for detail
- Formula
- C149H246N44O42S
- Molecular weight
- 3357.88 g/mol
Interactive
Reconstitution
Vial mass
mL
mcg
Syringe
- Draw to
- 25.0 units
- Volume
- 0.250 mL
- Concentration
- 1.00 mg/mL
- Draws per vial
- 8
Arithmetic for Sermorelin at the values you entered. Not a protocol and not a dose recommendation. Research use only.
Handling
- On arrival
- Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
- Reconstitution
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- After reconstitution
- 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
- Shelf life
- 24 months lyophilised, desiccated and protected from light.